Interview With Julie Kim, Global Franchise Head Of BioTherapeutics, Baxter Int'l. Inc.
By Pharmaceutical Engineering Magazine
Julie Kim is the General Manager for the global franchise, the BioTherapeutics Franchise, which includes a portfolio of anitbody-replacement therapies, albumin, and a number of specialty plasma proteins that are available globally.
She began her career in the strategy function in 2001 on key issues across the BioScience division. Over the next 10 years, she advanced through positions of increasing responsibility within BioScience in market development in emerging geographies and global marketing roles. Prior to joining Baxter, Kim worked in healthcare consulting for more than seven years. In addition, Kim is passionate about corporate sustainability and diversity and inclusion. She sits on the Baxter Sustainability Steering Committee, the BioScience Diversity and Inclusion Committee and is an advisor of multiple Business Resource Groups.
copy® September/October 2013, ISPE